LLY stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
Ricks David A2023/05/10SVP and Pres, Lilly Bio-Meds170728-408462023-05-1000000594780000059478129882
-
Hedley Mary Lynne2023/05/09512023-05-090000059478000005947851
-
Hedley Mary Lynne2023/05/08512023-05-080000059478000005947851
-
Hedley Mary Lynne2023/05/07512023-05-070000059478000005947851
-
Hedley Mary Lynne2023/05/06512023-05-060000059478000005947851
-
LECHLEITER JOHN C2023/05/05President and COO155390-766662023-05-050000059478000005947878724
-
Hedley Mary Lynne2023/05/04512023-05-040000059478000005947851
-
Ricks David A2023/05/03SVP and Pres, Lilly Bio-Meds170728-408462023-05-0300000594780000059478129882
-
Skovronsky Daniel2023/05/02SVP, CSO, and Pres. LRL1105572023-05-0200000594780000059478110557
-
Ricks David A2023/05/01SVP and Pres, Lilly Bio-Meds170728-408462023-05-0100000594780000059478129882
Related News

ASML Stock Falls 14% Since February High—Can NASDAQ:ASML Reclaim Its Uptrend?
TradingNEWS Archive
28.04.25

Tesla (NASDAQ:TSLA) Advances to $295.50 on Full Self-Driving Gains and Production Efficiencies
TradingNEWS Archive
28.04.25

Pfizer Stock at $22.50—Could That 7.6% Yield and a $64 B Revenue Outlook Turn PFE Around?
TradingNEWS Archive
25.04.25